U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07015528) titled 'Assessment of Drug Liking In Peri-procedural Clinical Settings' on June 03.
Brief Summary: The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Drug Liking
Intervention:
DRUG: Anti-dopaminergic Medication
Up to 2.5 mg given by single intravenous (IV) administration.
DRUG: Placebo
Matching Placebo given by single intravenous (IV) administration.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Stanford University
Information provided by (Responsible Party): Patrick Purdon, Stanford ...